Resources from the same session
3200 - CTONG 1509 : Phase 3 study of bevacizumab with or without erlotinib in untreated Chinese patients with advanced EGFR-mutated NSCLC
Presenter: Qing Zhou
Session: Proffered Paper 2 - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
1783 - Clinical development of molecular-targeted therapies for non-small cell lung cancer through nationwide genome screening in Japan (LC-SCRUM-Japan)
Presenter: Shingo Miyamoto
Session: Proffered Paper 2 - NSCLC, metastatic
Resources:
Abstract
Slides
4580 - Outcomes with pembrolizumab (pembro) monotherapy in patients (pts) with PD-L1–positive NSCLC with brain metastases: Pooled analysis of KEYNOTE-001, -010, -024, and -042
Presenter: Aaron Mansfield
Session: Proffered Paper 2 - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast
5026 - Phase II/III Blood First Assay Screening Trial (BFAST) in patients (pts) with treatment-naïve NSCLC: initial results from the ALK+ cohort
Presenter: Shirish Gadgeel
Session: Proffered Paper 2 - NSCLC, metastatic
Resources:
Abstract
Slides
Webcast